文献速递产科母胎医学

宫颈环扎术治疗无既往自发性早产史的单胎妊娠超声短宫颈:基于个体患者数据的随机对照试验系统综述与Meta分析

Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data.
PubMed 文献 · Ultrasound Obstet Gynecol · 2017-10-05

本系统综述与Meta分析纳入5项随机对照试验共419例无既往自发性早产史、孕中期经阴道超声宫颈长度<25 mm的无症状单胎妊娠,比较宫颈环扎术与不环扎的疗效。结果显示环扎术未显著降低<35周早产率(21.9% vs 27.7%;RR 0.88,95%CI 0.63-1.23),但在宫颈长度<10 mm亚组及联合宫缩抑制剂或抗生素亚组中早产率显著降低。证据质量评为低。

要点

  • 对于无既往自发性早产史、孕中期宫颈长度<25 mm的单胎妊娠,宫颈环扎术未显著降低<35周早产率。
  • 宫颈长度<10 mm者接受环扎术后<35周早产率显著低于未环扎者(39.5% vs 58.0%;RR 0.68,95%CI 0.47-0.98)。
  • 环扎术联合宫缩抑制剂或抗生素时<35周早产率显著降低,但证据质量低,需进一步研究。

核心结论

  • 在无既往自发性早产史但孕中期经阴道超声宫颈长度<25 mm的单胎妊娠中,宫颈环扎术似乎不能预防早产或改善新生儿结局。
  • 在这些妊娠中,宫颈环扎术似乎在更短的宫颈长度(如<10 mm)以及当宫缩抑制剂或抗生素作为辅助治疗时有效,需在这些亚组中进一步研究。
  • 鉴于证据质量低,需要进一步精心设计的随机对照试验来证实本研究的发现。

研究设计与样本

  • 系统综述与Meta分析,检索各电子数据库自建库至2017年2月,无语言限制。
  • 纳入无症状单胎妊娠、无既往自发性早产史、孕中期经阴道超声宫颈长度<25 mm并随机接受宫颈环扎术或不环扎的随机对照试验。
  • 联系所有纳入试验的通讯作者获取个体患者数据,合并构建专用主数据库进行分析。
  • 共纳入5项随机对照试验,包括419例无症状单胎妊娠。
  • 主要结局为<35周早产,效应量以相对危险度(RR)及95%CI表示,证据质量采用GRADE方法评估。

主要发现

  • 环扎组与对照组<35周早产率分别为21.9%与27.7%(RR 0.88,95%CI 0.63-1.23;I²=0%;5项研究,419例),差异无统计学意义。
  • 环扎组与对照组在<34周、<32周、<28周、<24周早产、分娩孕周、未足月胎膜早破(PPROM)及新生儿结局方面均无统计学显著差异。
  • 宫颈长度<10 mm亚组中,环扎组与未环扎组<35周早产率分别为39.5%与58.0%(RR 0.68,95%CI 0.47-0.98;I²=0%;5项研究,126例)。
  • 接受宫缩抑制剂作为辅助治疗的亚组中,环扎组与未环扎组<35周早产率分别为17.5%与32.7%(RR 0.54,95%CI 0.31-0.93;I²=0%;4项研究,169例)。
  • 接受抗生素作为辅助治疗的亚组中,环扎组与未环扎组<35周早产率分别为18.3%与31.5%(RR 0.58,95%CI 0.33-0.98;I²=0%;3项研究,163例)。

关键数值与推荐

  • 证据质量因严重不精确性和间接性被降两级,判定为低质量。

临床怎么用

  • 作者认为,对于无既往自发性早产史但孕中期宫颈长度<25 mm的单胎妊娠,宫颈环扎术似乎不能预防早产或改善新生儿结局。
  • 作者认为,在这些妊娠中,宫颈环扎术似乎在宫颈长度更短(如<10 mm)以及当宫缩抑制剂或抗生素作为辅助治疗时有效,需在这些亚组中进一步研究。
  • 作者建议,鉴于证据质量低,需要进一步精心设计的随机对照试验来证实本研究的发现。

局限性

  • 证据质量因严重不精确性和间接性被降两级,判定为低质量。
  • 作者指出需在宫颈长度<10 mm及联合宫缩抑制剂或抗生素的亚组中进一步研究。
  • 作者指出鉴于证据质量低,需要进一步精心设计的随机对照试验来证实本研究的发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this systematic review and meta-analysis was to quantify the efficacy of cervical cerclage in preventing preterm birth (PTB) in asymptomatic singleton pregnancies with a short mid-trimester cervical length (CL) on transvaginal sonography (TVS) and without prior spontaneous PTB. METHODS: Electronic databases were searched from inception of each database until February 2017. No language restrictions were applied. All randomized controlled trials (RCTs) of asymptomatic singleton pregnancies without prior spontaneous PTB, found to have short CL < 25 mm on mid-trimester TVS and then randomized to management with either cerclage or no cerclage, were included. Corresponding authors of all the included trials were contacted to obtain access to the data and perform a meta-analysis of individual patient-level data. Data provided by the investigators were merged into a master database constructed specifically for the review. Primary outcome was PTB < 35 weeks. Summary measures were reported as relative risk (RR) with 95% CI. The quality of the evidence was assessed using the GRADE approach. RESULTS: Five RCTs, including 419 asymptomatic singleton gestations with TVS-CL < 25 mm and without prior spontaneous PTB, were analyzed. In women who were randomized to the cerclage group compared with those in the control group, no statistically significant differences were found in PTB < 35 (21.9% vs 27.7%; RR, 0.88 (95% CI 0.63-1.23); I2 = 0%; five studies, 419 participants), < 34, < 32, < 28 and < 24 weeks, gestational age at delivery, preterm prelabor rupture of membranes (PPROM) and neonatal outcomes. In women who received cerclage compared with those who did not, planned subgroup analyses revealed a significantly lower rate of PTB < 35 weeks in women with TVS-CL < 10 mm (39.5% vs 58.0%; RR, 0.68 (95% CI, 0.47-0.98); I2 = 0%; five studies; 126 participants) and in women who received tocolytics (17.5% vs 32.7%; RR, 0.54 (95% CI, 0.31-0.93); I2 = 0%; four studies; 169 participants) or antibiotics (18.3% vs 31.5%; RR, 0.58 (95% CI, 0.33-0.98); I2 = 0%; three studies; 163 participants) as additional therapy to cerclage. The quality of evidence was downgraded two levels because of serious imprecision and indirectness, and therefore was judged as low. CONCLUSIONS: In singleton gestations without prior spontaneous PTB but with TVS-CL < 25 mm in the second trimester, cerclage does not seem to prevent preterm delivery or improve neonatal outcome. However, in these pregnancies, cerclage seems to be efficacious at lower CLs, such as < 10 mm, and when tocolytics or antibiotics are used as additional therapy, requiring further studies in these subgroups. Given the low quality of evidence, further well-designed RCTs are needed to confirm the findings of this study. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Berghella V, Ciardulli A, Rust OA, et al. Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol. 2017. PMID: 28295722. doi:10.1002/uog.17457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。